Cullinan Therapeutics Inc... (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
6.94
0.49 (7.60%)
At close: Oct 09, 2025, 10:58 AM
7.60% (1D)
| Bid | 6.89 |
| Market Cap | 409.83M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -206.76M |
| EPS (ttm) | -3.16 |
| PE Ratio (ttm) | -2.2 |
| Forward PE | -1.65 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.99 |
| Volume | 2,048,931 |
| Avg. Volume (20D) | 590,010 |
| Open | 6.50 |
| Previous Close | 6.45 |
| Day's Range | 6.50 - 7.08 |
| 52-Week Range | 5.68 - 17.98 |
| Beta | -0.12 |
| Ex-Dividend Date | n/a |
About CGEM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
